Cidara Therapeutics, Inc.CDTXNASDAQ
LOADING
|||
Price to Sales: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-sales ratio
Latest
133.87
↑ 784% above average
Average (9y)
15.14
Historical baseline
Range
High:133.87
Low:0.00
Volatility
884.2%
High variability
| Period | Value | Change |
|---|---|---|
| 2024 | 133.87 | +4389.9% |
| 2023 | 2.98 | +263.6% |
| 2022 | 0.82 | -39.0% |
| 2021 | 1.34 | -80.5% |
| 2020 | 6.89 | +25.3% |
| 2019 | 5.50 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |